Tag Archives: Farmaceutica

Pharma, a wholly owned subsidiary of Biocon, has partnered with Brazil’s Libbs Farmaceutica to launch generic drugs in the South American country. This partnership, which marks the entry of Biocon’s generic formulations into Latin America, builds upon a successful association with Libbs, which began in 2017 to launch biosimilar Trastuzumab …

Read More »